Paradigm Biopharma on track to US Phase III osteo program
Paradigm Biopharma (ASX:PAR) has announced its completion of a submission to the…
Change | ||
S&P/ASX Sm. Ords. | |||
All Ordinaries | |||
S&P/ASX 100 |
DY6 | DY6 METALS LTD | 5.7¢ | 54.1% |
AI1 | ADISYN LTD | 2.6¢ | 30.0% |
WBE | WHITEBARK ENERGY LTD | 1.6¢ | 23.1% |
TNY | TINYBEANS GROUP LTD | 5.1¢ | 45.7% |
GTG | GENETIC TECHNOLOGIES LIMITED | 13.5¢ | 22.9% |
FNR | FAR NORTHERN RESOURCES LIMITED | 15.5¢ | 20.5% |